FAST BioMedical is a late clinical-stage medical technology company located in Indianapolis. The company’s globally patented technology is being developed to directly measure volume status (Plasma Volume) and kidney function (mGFR) in a clinically actionable way, which has the potential for significant impact on the treatment of patients with heart failure, cardio-renal syndrome, major surgery, sepsis, and acute kidney injury (AKI). FAST BioMedical has completed five clinical studies in Germany and the United States and has a broad global patent portfolio. A 2021 MedTech Innovator Showcase 50 Company.
Connect with us at www.fastbiomedical.com or follow us on Twitter: www.twitter.com/fastbiomedical
Company’s Keywords:
diagnostics, medical devices, product development, us & eu codevelopment, heart failure, cardiorenal syndrome, acute kidney injury, medical technology
5
medical devices
5000000
Outlook, Microsoft Office 365, Microsoft Azure Hosting, Mobile Friendly, Google Tag Manager, reCAPTCHA, YouTube, Google Font API, Google Analytics
2006
Your request has been submitted successfully.
Own or work here?